The increasing prevalence of blood diseases and disorders pose a global health challenge and are associated with high morbidity and mortality. From the patients’ perspective, this has led to increasing awareness of diseases and shift from sickness to wellness.
Look at it from the perspective of the IVD industry: hematology has grown to be recognized as a distinct steam of laboratory medicine. Technological advancements, increasing adoption of automated hematology instruments, integration of basic flow-cytometry techniques, usage of microfluidics technology, introduction of digital imaging for cell morphology, rising demand for high-throughput hematology analyzers, and development of high-sensitivity point-of-care (POC) hematology testing are all factors contributing to the growth of this segment.
Asia-Pacific is estimated to be the fastest-growing market due to the rapidly developing healthcare infrastructure and increased funding. Speaking of India, the hematology market has yielded close to Rs. 1300 crore for FY 2018-19.
Technological advancements in this segment have led to reporting of advanced parameters even by the most basic automated analyzers. These parameters provide detailed clinical insights for the differential diagnosis of various blood disorders. Particularly relevant in India, these parameters help in detection of anemia and other hemoglobinopathies. Ironically, there is still a large section of the society, which is devoid of basic laboratory investigations.
To add to that, factors such as high cost of instruments, regulatory constraints, and strong competition act as roadblocks.
Limited access to quality medical infrastructure, including skilled manpower and technologies, has been the pain points of over 70 percent of Indians who live in smaller towns and rural areas. The need of the hour is for Indian manufacturers to cater to this 70 percent. This can be done by providing latest technological advancements at affordable rates.
Transasia Bio-Medicals Ltd., one of the India’s leading IVD company, has been providing Make in India products with an aim to provide affordable diagnostic solutions. Recently, Transasia introduced its latest range of 3- and 5-part fully automated hematology analyzers, which have been developed at Erba Europe, the global R&D facility of Transasia. These instruments are set to provide affordable diagnosis to cater to the masses.